{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:00:52Z","timestamp":1791176452310,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":951,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1038\/mt.2013.267","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T19:04:11Z","timestamp":1385492651000},"page":"547-553","source":"Crossref","is-referenced-by-count":50,"title":["Effective Intravenous Therapy for Neurodegenerative Disease With a Therapeutic Enzyme and a Peptide That Mediates Delivery to the Brain"],"prefix":"10.1016","volume":"22","author":[{"given":"Yu","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Sohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E","family":"Sleat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R","family":"Reuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gobinda","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2013.267_bib1","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis","volume":"277","author":"Sleat","year":"1997","journal-title":"Science"},{"key":"10.1038\/mt.2013.267_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ajmg.1320420428","article-title":"Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease)","volume":"42","author":"Palmer","year":"1992","journal-title":"Am J Med Genet"},{"key":"10.1038\/mt.2013.267_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10545-010-9093-7","article-title":"The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations","volume":"33","author":"Poupetov\u00e1","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/mt.2013.267_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-8-19","article-title":"Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy","volume":"8","author":"Santorelli","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1038\/mt.2013.267_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-genom-090711-163739","article-title":"Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges","volume":"13","author":"Desnick","year":"2012","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1038\/mt.2013.267_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","article-title":"Enzyme replacement for lysosomal diseases","volume":"57","author":"Brady","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1038\/mt.2013.267_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/emmm.201302668","article-title":"The final frontier \u2013 crossing the blood-brain barrier","volume":"5","author":"Sly","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1038\/mt.2013.267_bib8","first-page":"S124","article-title":"Novel treatments and future perspectives: outcomes of intrathecal drug delivery","volume":"47(suppl. 1)","author":"Dickson","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1038\/mt.2013.267_bib9","first-page":"S118","article-title":"Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases","volume":"47(suppl. 1)","author":"Hemsley","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1038\/mt.2013.267_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2011.06.018","article-title":"Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"104","author":"Vuillemenot","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2013.267_bib11","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/mt.2011.130","article-title":"Large-volume intrathecal enzyme delivery increases survival of a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"19","author":"Xu","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.267_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.267_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/B978-0-12-396962-0.00011-2","article-title":"Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier","volume":"503","author":"Pardridge","year":"2012","journal-title":"Meth Enzymol"},{"key":"10.1038\/mt.2013.267_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.expneurol.2011.04.004","article-title":"Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA","volume":"230","author":"Rozaklis","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2013.267_bib15","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1073\/pnas.78.9.5838","article-title":"Delivery of hexosaminidase A to the cerebrum after osmotic modification of the blood\u2013brain barrier","volume":"78","author":"Neuwelt","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.267_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/emmm.201202083","article-title":"A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA","volume":"5","author":"Sorrentino","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1038\/mt.2013.267_bib17","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.1222742110","article-title":"Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier","volume":"110","author":"Wang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.267_bib18","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1073\/pnas.0712147105","article-title":"Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII","volume":"105","author":"Grubb","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.267_bib19","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1073\/pnas.1214779109","article-title":"Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII","volume":"109","author":"Huynh","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.267_bib20","doi-asserted-by":"crossref","first-page":"14777","DOI":"10.1073\/pnas.0506892102","article-title":"Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII","volume":"102","author":"Vogler","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.267_bib21","doi-asserted-by":"crossref","first-page":"e40509","DOI":"10.1371\/journal.pone.0040509","article-title":"Systemic administration of tripeptidyl peptidase I in a mouse model of late infantile neuronal ceroid lipofuscinosis: effect of glycan modification","volume":"7","author":"Meng","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1038\/mt.2013.267_bib22","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/hmg\/ddh220","article-title":"Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study","volume":"13","author":"Roces","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2013.267_bib23","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.1093\/hmg\/ddq420","article-title":"Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy","volume":"19","author":"Polito","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2013.267_bib24","doi-asserted-by":"crossref","first-page":"e28881","DOI":"10.1371\/journal.pone.0028881","article-title":"A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brain","volume":"6","author":"Sarkar","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1038\/mt.2013.267_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0006-8993(87)90705-0","article-title":"Intracarotid infusions of protamine sulfate disrupt the blood-brain barrier of rabbits","volume":"409","author":"Strausbaugh","year":"1987","journal-title":"Brain Res"},{"key":"10.1038\/mt.2013.267_bib26","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1172\/JCI116825","article-title":"Protamine-mediated transport of albumin into brain and other organs of the rat. Binding and endocytosis of protamine-albumin complex by microvascular endothelium","volume":"92","author":"Pardridge","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2013.267_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ab.2007.03.020","article-title":"Engineering a noncarrier to a highly efficient carrier peptide for noncovalently delivering biologically active proteins into human cells","volume":"365","author":"Mahlum","year":"2007","journal-title":"Anal Biochem"},{"key":"10.1038\/mt.2013.267_bib28","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","article-title":"A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration","volume":"24","author":"Sleat","year":"2004","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2013.267_bib29","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/clinchem\/46.7.1005","article-title":"Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase I and pepstatin-insensitive protease assays","volume":"46","author":"Sohar","year":"2000","journal-title":"Clin Chem"},{"key":"10.1038\/mt.2013.267_bib30","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1074\/jbc.M806943200","article-title":"Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis","volume":"284","author":"Guhaniyogi","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2013.267_bib31","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/sj.mt.6300249","article-title":"Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease","volume":"15","author":"Cabrera-Salazar","year":"2007","journal-title":"Mol Ther"},{"issue":"Pt 1","key":"10.1038\/mt.2013.267_bib32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/bj3570049","article-title":"Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis","volume":"357","author":"Lin","year":"2001","journal-title":"Biochem J"},{"key":"10.1038\/mt.2013.267_bib33","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.neuro.2012.08.003","article-title":"Effects of synthetic cathinones contained in \u201cbath salts\u201d on motor behavior and a functional observational battery in mice","volume":"33","author":"Marusich","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1038\/mt.2013.267_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0270(01)00485-X","article-title":"A simple method to measure stride length as an index of nigrostriatal dysfunction in mice","volume":"113","author":"Fernagut","year":"2002","journal-title":"J Neurosci Methods"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616311790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616311790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T20:33:33Z","timestamp":1597091613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616311790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1525001616311790"],"URL":"https:\/\/doi.org\/10.1038\/mt.2013.267","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}